Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Sanofi Winthrop Industrie Gentilly FR

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

CEP 1999-043 - Rev 08
Valid
Chemical
2024-02-16
475
Sanofi Company Banner

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Certificate Number : CEP 1999-043 - Rev 08

Status : Valid

Issue Date : 2024-02-16

Type : Chemical

Substance Number : 475

Sanofi Company Banner

Looking for Certificates of Suitability (CEPs) for CEP 1999-043 - Rev 08 of Sanofi Winthrop Industrie Gentilly Fr

Looking for Certificates of Suitability (CEPs) for CEP 1999-043 - Rev 08 of Sanofi Winthrop Industrie Gentilly Fr 1

20

Sanofi Winthrop Industrie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their significant offerings is Chlorpromazine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 1999-043 - Rev 08

This Chemical Type CEP, issued on February 16, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 475 associated with this CEP further emphasizes